Company Overview of Lysosomal Therapeutics Inc.
Lysosomal Therapeutics Inc. is engaged in small-molecule research and development in the field of neurodegenerative diseases to discover new drugs for patients with severe neurological diseases. The company provides services to target Gaucher-related neurodegeneration, Parkinson’s disease, and other synucleinopathies. Lysosomal Therapeutics Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.
19 Blackstone Street
Cambridge, MA 02139
Founded in 2011
Key Executives for Lysosomal Therapeutics Inc.
Lysosomal Therapeutics Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Lysosomal Therapeutics Inc., please visit www.lysosomaltx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.